About Index Trending news
Analyze
Pricing
ProMetic

ProMetic

ProMetic

ProMetic is a global biopharmaceutical company offering technologies for largescale drug purification, drug development, proteomics (the study of proteins), and the elimination of pathogens.

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding Show all
Post-IPO equity
$9,500,000
Private equity
California Capital Equity
Employees

Team size

50+
Locations
HQ
Headquarters
$9,500,000 Post-IPO equity
biospace

ProMetic Life Sci Receives 9 5 Million Purchase Order From Multinational Client

PE Hub

Prometic to raise additional $25 mln from Thomvest vehicle

Funding Stock markets
Private equity
PE Hub

California Capital Equity ups equity stake in ProMetic Life Sciences - PE Hub

Funding Science
$30,000,000 Debt financing
FierceBiotech

ProMetic raises $30 million